<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000723439"><TermName>Nucynta</TermName><TermPronunciation>(noo-SIN-tuh)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat moderate to severe pain. It binds to opioid receptors and other molecules in the central nervous system. Nucynta is a type of opioid and a type of analgesic agent. Also called tapentadol hydrochloride.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000734735" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Nucynta&quot;" language="en" id="_3"/><MediaLink ref="CDR0000734734" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Nucynta&quot;" language="es" id="_4"/><SpanishTermName>Nucynta</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar el dolor moderado a grave. Se une a los receptores de opioides y otras moléculas del sistema nervioso central. Nucynta es un tipo de opioide y un tipo de analgésico. También se llama clorhidrato de tapentadol.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2012-04-11</DateFirstPublished></GlossaryTerm>
